Scientists and Industry Gather in 2 Weeks for 18th Annual Superbugs Meeting

LONDON - March 1, 2016 - PRLog -- In just 2 weeks, SMi’s 18th annual scientific meeting on Superbugs & Superdrugs will gather a truly global audience of antimicrobial experts and senior industry thought leaders involved in infectious disease from Austria, Belgium, Croatia, Denmark, Finland, France, Netherlands, Singapore, Sweden, Switzerland, United Kingdom and USA.

Attendees will also be invited to share their expertise and participate in the panel discussion on tackling the major bottlenecks that hinder development of new antibacterial drugs. As well as reviewing "true" point of care with field based testing and exploring multifaceted infection control programmes, the debate will ask questions such as: Is the biotech sector the forgotten partner in developing new treatments for AMR? Regulatory environment for non-traditional therapies - is a new paradigm needed? Is giving taxpayer money to pharmaceutical companies the best way of stimulating the development of new anti-infectives?

A new keynote address has also just been added onto the agenda from Dr Jorge Mestre-Ferrandiz, Director of Consulting at the Office of Health Economics. The presentation entitled, “New Business Models for Antibiotics: Where are we now?” will discuss current economic challenges and address both on-going and future initiatives.

Other event highlights will include a progressive insight on portfolio partnerships and funding opportunities presented by BARDA; and a keynote address offering a future outlook on antibiotic alternatives by industry expert, Lloyd Czaplewski, Director of Chemical Biology Ventures.

This is just a snap shot of what will be covered. Visit the website to download a brochure and see the full agenda featuring presentations from the European Commission, Centre for Anti-Infective Agents, Cempra Pharmaceuticals, Transcrip Partners, Blueberry Therapeutics, Spero Therapeutics, plus many more. An attendee list is also available to view in the event download centre at www.superbugssuperdrugs.com

SMi’s 18th annual conference:
Superbugs & Superdrugs
16th & 17th March 2016
Holiday Inn Kensington Forum, London UK

-- END ---

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk